Videos / The A to Z of testosterone therapy for women in clinical practice

The A to Z of testosterone therapy for women in clinical practice

Description

Chairman: Dr Rod Baber, GP and Medical Educator

Guests: Prof Susan Davis AO, Consultant Endocrinologist and Prof Janice Rymer, Professor of Obstetrics and Gynaecology

Total time: 66 mins

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

NEXT LIVE Webcast

Days

Hours

Minutes

Seconds

Dr Rupert Hinds

Functional Gastrointestinal Disorders in Infants – Practical Advice for HCPs

Dr Shannon Thomas

TIAs and Carotid Stenosis

Dr Ginni Mansberg

Low libido - What is it & How is it Managed?

A/Prof Michael Woodward AM

Using the New RSV Vaccine in Practice

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

30 April 2024

expert

Prof Rod Baber

Obstetrician and Gynaecologist; Clinical Professor, Obstetrics, Gynaecology and Neonatology, Northern Clinical School, The University of Sydney; Head of Menopause and Menstrual Disorders Clinic, Royal North Shore Hospital

Prof Susan Davis AO

Consultant Endocrinologist; Head of Specialist Women’s Health Clinic, Alfred Hospital Melbourne; Director, Monash University Women’s Health Research Program

Prof Janice Rymer

Dean of Student Affairs, Professor of Obstetrics and Gynaecology

Fezolinetant for vasomotor symptoms associated with menopause

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

Date published: 8 November 2022

Next up

Browse the latest videos from Healthed.

Drugs and devices, Sexual health, Women's health

Fezolinetant for vasomotor symptoms associated with menopause

In this Product Explainer, Obstetrician and Gynaecologist Prof Rod Baber explains the role of fezolinetant for the treatment of vasomotor symptoms associated with menopause...

Drugs and devices, Geriatric medicine, Infectious diseases, Vaccination

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

The A to Z of testosterone therapy for women in clinical practice

Description